The State Food and Drug Administration held a key laboratory work exchange and promotion meeting

On March 5, the State Food and Drug Administration held a key laboratory work exchange and promotion meeting to analyze the situation, exchange experience, clarify tasks, and promote the work of key laboratories to a new level

Xu Jinghe pointed out that doing a good job in the construction of key laboratories is the need to accelerate the leap from a major pharmaceutical country to a strong pharmaceutical country, to accelerate the modernization of the drug regulatory system and regulatory capabilities, and to accelerate the implementation of China's drug regulatory scientific action plan.

At the meeting, representatives of 5 laboratories gave speeches

The Key Laboratory of Biomaterial Safety Evaluation was jointly declared by the Shandong Medical Device Inspection Center and the Biomaterials Joint Testing Center of Sichuan University.

The key laboratory of cosmetics monitoring and evaluation relies on the construction of Shanghai Food and Drug Inspection and Research Institute

The Key Laboratory of Generic Drug Research and Evaluation is composed of Beijing Institute of Drug Control, National Pharmacopoeia Commission, and Institute of Materia Medica, Chinese Academy of Medical Sciences

Relying on the construction of Beijing University of Traditional Chinese Medicine, the Key Laboratory of Chinese Medicine Research and Evaluation is one of the second batch of newly established key laboratories

In recent years, provincial drug regulatory authorities have actively participated in the construction of key laboratories of the State Food and Drug Administration, and have achieved remarkable results in several aspects

Xu Jinghe fully affirmed the work effect of the key laboratory and put forward two requirements for the next key laboratory construction

The meeting was held in a combination of online and offline methods.

Source: official website of the State Drug Administration